Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

被引:52
作者
Zamboglou, Constantinos [1 ,8 ,9 ]
Thomann, Benedikt [2 ,8 ]
Koubar, Khodor [2 ,8 ]
Bronsert, Peter [3 ,8 ]
Krauss, Tobias [5 ,8 ]
Rischke, Hans C. [1 ,8 ]
Sachpazidis, Ilias [2 ,8 ]
Drendel, Vanessa [3 ,8 ]
Salman, Nasr [1 ,8 ]
Reichel, Kathrin [6 ,8 ]
Jilg, Cordula A. [6 ,8 ]
Werner, Martin [3 ,8 ]
Meyer, Philipp T. [4 ,8 ]
Bock, Michael [7 ,8 ]
Baltas, Dimos [2 ,8 ]
Grosu, Anca L. [1 ,8 ]
机构
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Robert Koch Str 3, D-79106 Freiburg, Germany
[2] Univ Freiburg, Fac Med, Med Ctr, Div Med Phys,Dept Radiat Oncol, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Dept Pathol, Med Ctr, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol, Freiburg, Germany
[6] Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Germany
[7] Univ Freiburg, Fac Med, Dept Radiol, Div Med Phys,Med Ctr, Freiburg, Germany
[8] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany
[9] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany
来源
RADIATION ONCOLOGY | 2018年 / 13卷
关键词
Prostate cancer; Focal therapy; MRI; PSMA PET/CT; MODULATED RADIATION-THERAPY; POSITRON-EMISSION-TOMOGRAPHY; COMPLICATION PROBABILITY; VOLUME HISTOGRAMS; TUMOR; RADIOTHERAPY; HISTOPATHOLOGY; DISTRIBUTIONS; IRRADIATION; FAILURES;
D O I
10.1186/s13014-018-1036-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Focal radiation therapy has gained of interest in treatment of patients with primary prostate cancer (PCa). The question of how to define the intraprostatic boost volume is still open. Previous studies showed that multiparametric MRI (mpMRI) or PSMA PET alone could be used for boost volume definition. However, other studies proposed that the combined usage of both has the highest sensitivity in detection of intraprostatic lesions. The aim of this study was to demonstrate the feasibility and to evaluate the tumour control probability (TCP) and normal tissue complication probability (NTCP) of radiation therapy dose painting using Ga-68-HBED-CC PSMA PET/CT, mpMRI or the combination of both in primary PCa. Methods: Ten patients underwent PSMA PET/CT and mpMRl followed by prostatectomy. Three gross tumour volumes (GTVs) were created based on PET (GTV-PET), mpMRl (GTV-MRI) and the union of both (GTV-union). Two plans were generated for each GTV. Plan95 consisted of whole-prostate IMRT to 77 Gy in 35 fractions and a simultaneous boost to 95 Gy (Plan95(PET)/Plan95(MRI)/Plan95(union)). Plan80 consisted of whole-prostate IMRT to 76 Gy in 38 fractions and a simultaneous boost to 80 Gy (Plan80(PET)/Plan80(MRI)/Plan80(union)). TCPs were calculated for GTV-histo (TCP-histo), which was delineated based on PCa distribution in co-registered histology slices. NTCPs were assessed for bladder and rectum. Results: Dose constraints of published protocols were reached in every treatment plan. Mean TCP-histo were 99.7% (range: 97%-100%) and 75.5% (range: 33%-95%) for Plan95(union) and Plan80(union), respectively. Plan95(union) had significantly higher TCP-histo values than Plan95(MRI) (p = 0.008) and Plan95(PET) (p = 0.008). Plan80(union) had significantly higher TCP-histo values than Plan80(MRI) (p = 0.012), but not than PIan80(PET) (p = 0.472). Plan95(MRI) had significantly lower NTCP-rectum than Plan95(union) (p = 0.012). No significant differences in NTCP-rectum and NTCP-bladder were observed for all other plans (p > 0.05). Conclusions: IMRT dose escalation on GTVs based on mpMRl, PSMA PET/CT and the combination of both was feasible. Boosting GTV-union resulted in significantly higher TCP-histo with no or minimal increase of NTCPs compared to the other plans.
引用
收藏
页数:9
相关论文
共 44 条
  • [1] Boosting imaging defined dominant prostatic tumors: A systematic review
    Bauman, Glenn
    Haider, Masoom
    Van der Heide, Uulke A.
    Menard, Cynthia
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 274 - 281
  • [2] High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience
    Blana, A
    Walter, B
    Rogenhofer, S
    Wieland, WF
    [J]. UROLOGY, 2004, 63 (02) : 297 - 300
  • [3] OPTIMAL DOSE DISTRIBUTION FOR ERADICATION OF HETEROGENEOUS TUMORS
    BRAHME, A
    AGREN, AK
    [J]. ACTA ONCOLOGICA, 1987, 26 (05) : 377 - 385
  • [4] A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps
    Casares-Magaz, Oscar
    van der Heide, Uulke A.
    Rorvik, Janie
    Steenbergen, Peter
    Muren, Ludvig Paul
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) : 111 - 116
  • [5] Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning
    Cellini, N
    Morganti, AG
    Mattiucci, GC
    Valentini, V
    Leone, M
    Luzi, S
    Manfredi, R
    Dinapoli, N
    Digesu', C
    Smaniotto, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 595 - 599
  • [6] Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11C-choline Positron Emission Tomography Scans
    Chang, Joe H.
    Joon, Daryl Lim
    Lee, Sze Ting
    Gong, Sylvia J.
    Anderson, Nigel J.
    Scott, Andrew M.
    Davis, Ian D.
    Clouston, David
    Bolton, Damien
    Hamilton, Christopher S.
    Khoo, Vincent
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : E691 - E696
  • [7] An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients
    Dean, C. J.
    Sykes, J. R.
    Cooper, R. A.
    Hatfield, P.
    Carey, B.
    Swift, S.
    Bacon, S. E.
    Thwaites, D.
    Sebag-Montefiore, D.
    Morgan, A. M.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1009) : 61 - 68
  • [8] Novel Preclinical and Radiopharmaceutical Aspects of [Ga-68]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
    Eder, Matthias
    Neels, Oliver
    Mueller, Miriam
    Bauder-Wust, Ulrike
    Remde, Yvonne
    Schaefer, Martin
    Hennrich, Ute
    Eisenhut, Michael
    Afshar-Oromieh, Ali
    Haberkorn, Uwe
    Kopka, Klaus
    [J]. PHARMACEUTICALS, 2014, 7 (07): : 779 - 796
  • [9] Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    Eiber, Matthias
    Weirich, Gregor
    Holzapfel, Konstantin
    Souvatzoglou, Michael
    Haller, Bernhard
    Rauscher, Isabel
    Beer, Ambros J.
    Wester, Hans-Juergen
    Gschwend, Juergen
    Schwaiger, Markus
    Maurer, Tobias
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 829 - 836
  • [10] Adaptive Radiation Therapy for Prostate Cancer
    Ghilezan, Michel
    Yan, Di
    Martinez, Alvaro
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (02) : 130 - 137